Status:
UNKNOWN
Interest of Eosinopia in the Diagnosis of Infection in the Emergency Department
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Eosinopenia
Eligibility:
All Genders
18+ years
Brief Summary
Several studies have described the interest of eosinopenia as a marker of infection in internal medicine or in intensive care units. Eosinopenia is an inexpensive and easily accessible biological mark...
Eligibility Criteria
Inclusion
- major patient
- patient suspected of infection and benefiting from the routine practice of NFS, whatever the indication during his / her visit to the emergency room.
- patient with or without criteria for bacterial infection
- patient affiliated to a social security scheme
- patient (or legal representative) who has agreed to participate in the study
Exclusion
- anti tumor chemotherapy
- immunosuppressive treatment
- corticotherapy
- antibiotherapy in progress
- malignant hemopathy
- evolutionary cancer
- refusal to participate in the study
- subjects under safeguard of justice
- subject under guardianship or curatorship
Key Trial Info
Start Date :
March 23 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2020
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT03467672
Start Date
March 23 2018
End Date
March 1 2020
Last Update
May 1 2019
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
CH de COLMAR
Colmar, France, 68024
2
CH de MULHOUSE
Mulhouse, France, 68051
3
Ch Selestat
Sélestat, France, 67600
4
Les Hôpitaux Universitaires de Strasbourg
Strasbourg, France, 67098